| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $45.4M-36.2% | $71.2M+12.6% | $63.2M+87.7% | $33.7M-34.8% | $51.7M+1.5% | $50.9M |
| Short-term investments | $145.5M-48.9% | $284.5M-34.0% | $431.0M+44.9% | $297.5M+99.8% | $148.9M-34.1% | $226.0M |
| Prepaid expenses and other current assets (Note 5) | $4.5M-31.7% | $6.5M-41.9% | $11.3M+59.5% | $7.1M+4.3% | $6.8M+50.4% | $4.5M |
| Property and equipment held for sale (Note 4) | $1.0M | $0 | — | — | — | — |
| Total current assets | $196.4M-45.8% | $362.3M-28.3% | $505.5M+48.5% | $340.3M+62.5% | $209.4M-28.0% | $290.8M |
| Property and equipment, net (Note 4) | $2.9M-46.8% | $5.5M+54.9% | $3.6M-20.5% | $4.5M-2.6% | $4.6M+6.6% | $4.3M |
| Operating lease right-of-use assets | $24.0M-12.0% | $27.2M+2149.6% | $1.2M-77.7% | $5.4M-14.3% | $6.3M | $0 |
| Restricted cash | $1.5M+0.0% | $1.5M+0.0% | $1.5M | $0 | — | — |
| Other non-current assets | $392K-9.9% | $435K+11.0% | $392K-0.5% | $394K-53.0% | $838K+85.8% | $451K |
| Total assets | $225.2M-43.3% | $396.9M-22.5% | $512.2M+46.1% | $350.6M+58.5% | $221.2M-25.1% | $295.5M |
| Accounts payable | $480K-91.9% | $6.0M+31.5% | $4.5M+186.8% | $1.6M-46.8% | $3.0M+46.9% | $2.0M |
| Accrued research and development | $4.8M-66.6% | $14.4M+15.3% | $12.5M+11.0% | $11.2M+91.2% | $5.9M | — |
| Accrued liabilities (Note 6) | $9.6M-22.0% | $12.4M+20.9% | $10.2M+18.0% | $8.7M | — | $9.6M |
| Lease liabilities, current | $1.4M+167.0% | $542K-58.9% | $1.3M-46.4% | $2.5M+31.5% | $1.9M | $0 |
| Total current liabilities | $16.4M-50.7% | $33.2M+16.5% | $28.5M+19.3% | $23.9M+42.1% | $16.8M+45.1% | $11.6M |
| Lease liabilities, non-current | $27.7M-6.0% | $29.4M | $0-100.0% | $3.4M-35.6% | $5.3M | $0 |
| Long-term debt (Note 7) | $0-100.0% | $30.2M+200.5% | $10.1M+1.3% | $9.9M | $0 | — |
| Total liabilities | $44.0M-52.6% | $92.9M+140.7% | $38.6M+3.5% | $37.3M+68.2% | $22.2M+77.7% | $12.5M |
| Preferred stock, $0.0001 par value 10,000,000 shares authorized at December 31, 2025 and 2024, none issued or outstanding at December 31, 2025 and 2024 | $0 | $0 | $0 | $0 | — | — |
| Common stock, $0.0001 par value; 300,000,000 shares authorized at December 31, 2025 and 2024; and 61,449,290 and 60,860,838 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively; | $6K+0.0% | $6K+0.0% | $6K+20.0% | $5K+66.7% | $3K | — |
| Additional paid-in capital | $1.04B+2.6% | $1.01B+4.2% | $973.0M+48.8% | $653.7M+57.8% | $414.3M+3.3% | $400.9M |
| Accumulated deficit | -$859.4M-21.0% | -$710.1M-42.1% | -$499.7M-47.7% | -$338.4M-57.3% | -$215.1M-82.5% | -$117.8M |
| Accumulated other comprehensive (loss) gain | -$15K-104.7% | $321K-7.0% | $345K+117.6% | -$2.0M-874.1% | -$201K-528.1% | -$32K |
| Total stockholders’ equity | $181.2M-40.4% | $304.1M-35.8% | $473.6M+51.1% | $313.3M+57.4% | $199.1M-29.7% | $283.1M |
| Total liabilities and stockholders’ equity | $225.2M-43.3% | $396.9M-22.5% | $512.2M+46.1% | $350.6M+58.5% | $221.2M-25.1% | $295.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.